ライフサイエンスコーパス: procedural complication

1 ospitalization for unstable angina, or major procedural complication.

2 roblems precluding outpatient care, or had a procedural complication.

3 malignant causes of biliary obstruction and procedural complications.

4 and rehospitalization, but similar risks of procedural complications.

5 r adverse cardiovascular events (MACEs), and procedural complications.

6 undergoing TA-TAVR or presenting with major procedural complications.

7 composite of in-hospital mortality and peri-procedural complications.

8 doscopist must have the capability to manage procedural complications.

9 s coronary intervention (PCI) are related to procedural complications.

10 was achieved in seven patients with no major procedural complications.

11 ring surgical removal, there were no serious procedural complications.

12 to model the calculated risk score and major procedural complications.

13 There were no procedural complications.

14 ocardial infarction (MI) unrelated to direct procedural complications.

15 atients, and appeared to be related to acute procedural complications.

16 The category next in frequency was procedural complications (1.76 claims per 1000 person-ye

17 Patient drive time (as a proxy for access), procedural complications, 1-year mortality, myocardial i

18 disease (22.2%), cardiac conditions (11.4%), procedural complications (11.0%), and endocrine issues (

19 (23.7%), 99 missed diagnoses (30.1%), and 54 procedural complications (16.4%); some cases were in mor

20 result in significantly more major and minor procedural complications (18.0% vs. 3.1%, p = 0.0004), m

21 associated with: 1) somewhat increased major procedural complications, 2) significantly higher freque

22 The most common cause of readmission was procedural complications (28.0%), followed by sepsis (8.

23 The rates of procedural complications (5.8%) and acute kidney injury

24 There were two procedural complications: a vasovagal episode requiring

25 There were four immediate procedural complications: Air emboli occurred in two pat

26 Procedural complications also tended to be lower among t

27 PCI and post-PCI characteristics, including procedural complications and discharge characteristics,

28 There were no procedural complications and four 30-day major adverse e

29 tions of SVGs have been associated with more procedural complications and higher restenosis rates com

30 ns who implant more ICDs have lower rates of procedural complications and in-hospital mortality, inde

31 Procedural complications and limb revascularization rate

32 logist were associated with a higher risk of procedural complications and lower likelihood of receivi

33 tral ViR was associated with higher rates of procedural complications and mid-term mortality compared

34 No procedural complications and no further recurrences were

35 afety concerns were noted, with low rates of procedural complications and no increase in symptomatic

36 Secondary analyses included procedural complications and outcomes by clinical indica

37 tion, clinical failures are driven mainly by procedural complications and restenosis, but the subsequ

38 Procedural complications and treatment were noted.

39 Secondary end points included procedural complications and type 4a periprocedural myoc

40 observed even in the absence of discernible procedural complications and was more common in patients

41 Patient factors, procedural complications, and operator experience are pr

42 mprovements in existing devices have reduced procedural complications, and scientific trials are inve

43 There were 96 (2.94%) observed procedural complications, and the Mayo Clinic risk score

44 Procedural complications are responsible for a small fra

45 luded all-cause mortality at 6 months, major procedural complications, bleeding, and access-site comp

46 ortic valve predilatation (BAVP) in reducing procedural complications, but there are few data to supp

47 variables were significantly correlated with procedural complications: cardiogenic shock, left main c

48 s mostly acute cardiac (52.9%, n=45), with a procedural complication composing a small fraction (7.1%

49 Procedural complications from PFO closure occurred in 14

50 th LEB, PVI was associated with fewer 30-day procedural complications, higher revascularization rates

51 -defibrillator (ICD) implantation volume and procedural complications in a contemporary, representati

52 Device implantation was successful without procedural complications in all patients, with significa

53 Reported procedural complications included 1 renal artery dissect

54 Procedural complications included conduit rupture requir

55 Procedural complications included death in 1.4%, sustain

56 Procedural complications including THV malpositioning, s

57 sociated with a slightly higher incidence of procedural complications, including no reflow (3.9% vers

58 Five patients had procedural complications: lead dislodgment in 4 requirin

59 example, few PCI readmissions are caused by procedural complications, limiting the extent to which i

60 Clinical outcomes included procedural complications, myocardial infarction (MI), an

61 Procedural complications occurred in 12 patients (1.7%)

62 Major procedural complications occurred in 4 of the 113 patien

63 Procedural complications occurred in 5 cases (1.4%) afte

64 Procedural complications occurred infrequently: graft pe

65 Fewer major procedural complications occurred with elective IABP ins

66 No major procedural complications occurred.

67 No major procedural complications occurred.

68 tamponade, ventricular arrhythmia, or other procedural complications occurred.

69 by the development of > or = 1 in-1ab minor procedural complication (odds ratio, 2.6; P < .0001).

70 ratio, 0.4; 95% CI, 0.25-0.64; P<0.001) and procedural complications (odds ratio, 0.4; 95% CI, 0.2-0

71 Most cases of NSP occurred as a procedural complication or as a complication of medical

72 There were no major procedural complications or deaths.

73 concluded the procedure with no significant procedural complications or discomfort.

74 Procedural complications or electrocardiogram changes oc

75 ccurred in 20.3% of patients, whereas 30-day procedural complications or later nonrestenosis events o

76 No major procedural complications or morbidity occurred.

77 vents: OR, 0.81; 95% CI, 0.30-2.18; P = .68; procedural complications: OR, 0.57; 95% CI, 0.11-1.22; P

78 e significant decreases in the prevalence of procedural complications, particularly in the realm of a

79 However, surgery carries a significant procedural complication rate and mortality.

80 However, the procedural complication rate exceeds that of myectomy.

81 aser sheaths is highly successful with a low procedural complication rate.

82 Procedural complication rates included 39 pericardial ta

83 n vein grafts have been associated with high procedural complication rates, including distal emboliza

84 ioplasty has excellent early results and low procedural complication rates, long-term outcome is temp

85 Six eligibility criteria (procedural complications rates; at least 10 patients; sa

86 tamponade is a potentially life-threatening procedural complication requiring emergent reversal of a

87 namic support among TF-TAVR patients, severe procedural complications requiring conversion to open su

88 However, the possibility of procedural complications such as coronary dissection, no

89 sus n=10 [15.9%]; P=0.027), driven mainly by procedural complications such as pneumothorax, major ble

90 These patients' records were searched for procedural complications, sufficiency of biopsy tissue,

91 treatment options are associated with lower procedural complications, the technical advances have ou

92 nteger risk score for estimating the risk of procedural complications using baseline, angiographic an

93 l differences between observed and predicted procedural complications using the Mayo Clinic risk scor

94 Incidence of procedural complications was low and comparable in both

95 The frequency of procedural complications was similar in the foam group (

96 Procedural complications were also similar (2.2% for gro

97 Procedural complications were also similar (2.8% for mul

98 Procedural complications were also similar (3.8% for mul

99 Procedural complications were as follows: emergency bypa

100 A TA approach and major procedural complications were independently associated w

101 Procedural complications were limited to clinically unim

102 le procedural times, and a low rate of early procedural complications were observed.

103 Procedural complications were recorded.

104 No procedural complications were reported.

105 Rates of procedural complications were similar in both genders.

106 ghly publicized manufacturer advisories, and procedural complications, which can adversely affect mor

107 equate infrastructure to cope with potential procedural complications will minimize potential patient

108 The Mayo clinic predictive model for procedural complications yielded excellent results when